QT interval prolongation after sertraline overdose: A case report

BMC Emergency Medicine

Volumn 5, Issue , 2005, Pages

  de Boer, Rudolf A ^a,b   van Dijk, Tonnis H ^a   Holman, Nicole D ^a   van Melle, Joost P ^a,b  

^a MARTINI HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TEMAZEPAM;

ADULT; ARTICLE; CASE REPORT; DROWSINESS; DRUG BLOOD LEVEL; DRUG OVERDOSE; ELECTROCARDIOGRAM; EMERGENCY WARD; FATIGUE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; PATIENT REFERRAL; QT PROLONGATION; SUICIDE ATTEMPT;

EID: 26244446650     PISSN: 1471227X     EISSN: 1471227X     Source Type: Journal    
DOI: 10.1186/1471-227X-5-5     Document Type: Article

References (12)

1. Meijer WE, Heerdink ER, Leufkens HG, Herings RMC, Egberts ACG, Nolen WA: Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 2004, 60:57-61.
2. Kelsey JE, Nemeroff CB: Selective serotonin reuptake inhibitors: introduction and overview. In Kaplan and Sadock's Comprehensive Textbook of Psychiatry 7th edition. Edited by: Sadock BJ, Sadock VA. Philadelphia: Lippincott Williams & Wilkins; 2000:2432-2435.
3. Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM: What clinicians should know about the QT interval. JAMA 2003, 289:2120-2127.
4. Gillespie JA, Clary CM: Medications that prolong the QT interval. JAMA 2003, 290:1025. (letter)
5. [http://www.mdbrowse.com/Druginf/S/sertraline.htm#Sertraline]
6. Sala M, Vicentini A, Brambilla P, Montomoli C, Jogia JR, Caverzasi E, Bonzano A, Piccinelli M, Barale F, De Ferrari GM: QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry 2005, 4:1.
7. Isbister GK, Bowe SJ, Dawson A, Whyte IM: Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004, 42:277-285.
8. Fisch C, Knoebel SB: Electrocardiographic findings in sertraline depression trials. Drug Invest 1992, 4:305-312.
9. Fabre LF, Abuzzahab FS, Amin M, Claghorn JL, Mendels J, Petrie WM, Dube S, Small JG: Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry 1995, 38:592-602.
10. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, McIvor M, Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701-709.
11. Amin M, Lehmann H, Mirmiran J: A double-blind, placebo-controlled dose-finding study with sertraline. Psychopharmacol Bull 1989, 25:164-167.
12. Preskorn SH: A tale of two patients. J Pract Psych Behav Health 1999:160-164 [http://www.preskorn.com/columns/9905.html.].